TABLE 2

Pharmacokinetic parameters of edaravone, edaravone sulfate, and edaravone glucuronide in Mrp4 knockout and wild-type mice

Edaravone was infused i.v. for 120 min. Each value was determined from the data shown in Figure 5 and the equations described under Materials and Methods. Each value represents the mean ± S.E. (n = 10-11).




Wild-type

Mrp4−/−
CLCRE (ml/min/kg) 8.63 ± 1.50 8.91 ± 1.65
CLtotal (ml/min/kg)
Edaravone 105 ± 5 104 ± 8
CLrenal, p
Edaravone (ml/min/kg) 0.915 ± 0.114 0.818 ± 0.129
Sulfate 7.33 ± 0.43 8.98 ± 1.17
Glucuronide 22.1 ± 1.8 19.6 ± 2.7
CLrenal, k
Sulfate (ml/min/kg) 4.92 ± 0.83 2.86 ± 0.53
Glucuronide 5.06 ± 1.18 2.01 ± 0.45*
Ckidney
Edaravone (nmol/g kidney) 7.79 ± 2.16 14.1 ± 2.7
Sulfate 32.8 ± 13.8 53.7 ± 15.4
Glucuronide 24.8 ± 11.2 65.7 ± 26.9
Kp, kidney
Edaravone 3.39 ± 1.08 6.82 ± 1.73
Sulfate 2.72 ± 1.19 7.58 ± 3.44
Glucuronide 5.47 ± 2.40 15.0 ± 6.0
Urinary recovery
Edaravone (% dose) 0.781 ± 0.057 0.730 ± 0.069
Sulfate 31.9 ± 1.9 26.6 ± 2.9
Glucuronide
26.9 ± 1.7
26.6 ± 3.2
  • * P < 0.05, significantly different from wild-type mice using Student's t-test.